Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance …
https://newsroom.cardinalhealth.com/2024-04-22-Cardinal-Health-Reaffirms-Fiscal-2024-non-GAAP-EPS-Guidance-and-Long-term-Targets-Amidst-Nonrenewal-of-OptumRx-Customer-Contracts
Web2 days ago · DUBLIN, Ohio, April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed.The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35.Despite the nonrenewal of the OptumRx …
DA: 10 PA: 47 MOZ Rank: 61